IPSC — Century Therapeutics Share News
0.000.00%
Last trade - 00:00- $264.37m
- $144.66m
- $109.16m
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview
Brief: Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger To Board Of Directors
Century Therapeutics posts smaller-than-expected Q1 net loss on lower R&D spend
Brief: Century Therapeutics Q1 Net Income USD -21.645 Million
Century Therapeutics 2025 net loss narrows beating estimates
Brief: Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing To Support Lead Program, Cnty-813
Century Therapeutics Q3 net loss widens, despite lower costs
Century Therapeutics Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: Century Therapeutics To Reduce Headcount By 51%
Brief: Century Therapeutics Q1 Net Income USD 76.56 Million
Brief: Century Therapeutics Receives Nasdaq Notice For Bid Price Deficiency
Brief: Century Therapeutics Q3 Net Income USD -31.226 Million
Brief: Century Therapeutics Strengthens Leadership Team With Appointments Of Chief Financial Officer And Chief Scientific Officer
Brief: Century Therapeutics Q2 Net Income USD -31.207 Million
Brief: Century Therapeutics Inc Files For Shelf Of Up To 7.9 Million Shares Of Common Stock By Selling Stockholders - SEC Filing
U.S. RESEARCH ROUNDUP-Cheesecake Factory, Netflix, Texas Roadhouse